Accuray Incorporated (Nasdaq: ARAY), is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies, the CyberKnife and TomoTherapy Systems, deliver the full range of radiation therapy and radiosurgery treatments.
Side effects of CyberKnife and TomoTherapy treatments are usually mild and temporary, and may include nausea, fatigue and skin irritation. As with any radiation treatment, the side effects can also be severe in some patients and lead to permanent injury or even death. Talk to your doctor to determine if treatment with the CyberKnife or TomoTherapy System is right for you.
Side effects of CyberKnife and TomoTherapy treatments are usually mild and temporary, and may include nausea, fatigue and skin irritation. As with any radiation treatment, the side effects can also be severe in some patients and lead to permanent injury or even death. Talk to your doctor to determine if treatment with the CyberKnife or TomoTherapy System is right for you.
Location: United States, California, Sunnyvale
Employees: 501-1000
Phone: +1 408-716-4600
Total raised: $120M
Founded date: 1999
Investors 2
| Date | Name | Website |
| - | Ascension ... | ascensionv... |
| 17.07.2021 | Baird Capi... | bairdcapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.05.2021 | - | $120M | - |
Mentions in press and media 10
| Date | Title | Description |
| 07.05.2021 | ACCURAY INCORPORATED Accuray Incorporated : Announces New $120 Million Credit Facility | SUNNYVALE, Calif., May 6, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced it has entered into a new five-year $80 million term loan and $40 million revolving credit facility with Silicon Valley Bank and a syndicate ... |
| 06.05.2021 | Accuray Announces New $120 Million Credit Facility | |
| 16.07.2012 | Accuray nabs imaging systems maker Morphormics for $5.7M | Accuray (NSDQ:ARAY) signed a definitive agreement to acquire medical imaging software systems maker Morphormics for $5.7 million, the company announced today. Privately held Morphormics, founded by faculty of the University of North Carolin... |
| 02.08.2011 | Accuray ups offering to $100 million | Funding Roundup | Updated: 08/02/2011 1:30 p.m. Accuray Inc. (NSDQ:ARAY) priced its proposed offering higher than previous estimates, coming in at $100 million in 3.75 percent convertible senior notes made available to institutional investors. The sale was s... |
| 26.07.2011 | Accuray announces $75 million offering | Funding Roundup | Accuray Inc. (NSDQ:ARAY) announced plans to launch a $75 million offering of senior convertible notes today. The notes, due Aug. 1, 2016, will be open to institutional investors and the Sunnyvale, Calif.-based company plans to offer the fir... |
| 13.06.2011 | Accuray closes $277 million TomoTherapy merger | Accuray Inc. (NSDQ:ARAY) completed its $277 million acquisition of TomoTherapy Inc. (NSDQ:TOMO), tying the bow on a deal first announced in March 2010. The closing roughly doubles Accuray’s footprint in the radiation oncology market. The Su... |
| 18.02.2010 | Rise Health of Chicago raises $1.5M for primary care support services | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 09.05.2007 | TomoTherapy, cancer-treatment system maker, gets enthusiastic IPO reception | TomoTherapy, a Madison, Wis.-based maker of imaging and radiation-treatment systems for cancer therapy, raised $222.3 million in an initial offering after its shares priced higher than the company’s original range. TomoTherapy shares, which... |
| 14.11.2006 | Robotic medical device maker, Accuray, files for $230M IPO | Robotic medical device maker Accuray, of Sunnyvale, has filed to raise up to $230 million in an initial public offering of stock. The offering is expected to be led by underwriters JPMorgan and UBS Investment Bank, according to the SEC fili... |
| - | Rise Health of Chicago raises $1.5M for primary care support services | CHICAGO, Illinois — Rise Health Inc. has raised $1.5 million in equity for its primary care physician support services, according to a document filed with the Securities and Exchange Commission. Seeking to help ease the burdens of the U.S. ... |